UPDATE 1-Biogen scraps two late-stage Alzheimer's trials
September 13, 2019 at 08:44 AM EDT
Biogen Inc and partner Eisai Co Ltd said on Friday they would abandon two late-stage trials testing experimental Alzheimer's treatment elenbecestat, months after scrapping trials of another drug for the memory-robbing disease.